Fine lines, wrinkles, and loss of elasticity
Many claims circulating online are anecdotal, reflecting individual experiences rather than controlled clinical evidence
Competing Interests Professor Melanie Davies has acted as a consultant/advisor and speaker for Eli Lilly, Novo Nordisk and Sanofi, has attended advisory boards for Abbvie, Amgen, AstraZeneca, Biomea Fusion, Carmot/Roche, Sanofi, Zealand Pharma Regeneron, GSK and EktaH and as a speaker for AstraZeneca and Boehringer Ingelheim
As a final measure of peptide accuracy, our analytical lab uses mass spectrometry to verify the theoretical molecular weight of each peptide
The existing research provides a strong scientific rationale for BPC-157's healing properties, but patients should work with qualified healthcare providers who understand both the evidence base and appropriate clinical applications